Pacira Pharmaceuticals buy Royal Bank of Canada
Start price
03.11.23
/
50%
€28.40
Target price
03.11.24
€54.04
Performance (%)
-46.48%
End price
04.11.24
€15.20
Summary
This prediction ended on 04.11.24 with a price of €15.20. The BUY prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals performed very badly with a performance of -46.48%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | -7.345% | -7.345% | -34.400% |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Royal Bank of Canada from $67.00 to $58.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Royal_Bank_of_Canada for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€19.10
31.07.24
31.07.24
€34.16
31.07.25
31.07.25
-5.24%
01.08.25
01.08.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
01.03.24
01.03.24
€41.56
01.03.25
01.03.25
-16.03%
02.03.25
02.03.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
03.10.23
03.10.23
€65.04
03.10.24
03.10.24
-45.99%
04.10.24
04.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€34.80
03.08.23
03.08.23
€62.07
03.08.24
03.08.24
-47.13%
04.08.24
04.08.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€40.00
01.03.23
01.03.23
€71.20
01.03.24
01.03.24
-34.50%
02.03.24
02.03.24

